- Juul Yanks Its Fruity and Candy-Flavored Vapes Amid Crackdown: Brainstorm HealthHappy Friday, readers! The e-cigarette reckoning is raging on as market titan Juul announced it will voluntarily stop selling flavored vape pods (other than plain old tobacco and menthol) ahead of an impending ban. This was, perhaps, inevitable. The Trump administration had already proposed a similar ban on all flavored pods. Juul’s decision isn’t quite […]
- Fitbit Teams Up With Drug Giants to Tackle a Serious Heart ConditionFitbit is partnering with Bristol-Myers Squibb and Pfizer for early AFib detection, a serious heart disease risk.
- Why Doctors May Not Be Prepared to Treat Prescription Drug AddictionA new report finds that a majority of physicians are concerned about a new prescription drug crisis.
- Bayer's Roundup Crisis Heats Up as It Braces for a 'Significant Surge' of New LawsuitsThe Roundup crisis has cost Bayer more than $30 billion in market value as the company lost three U.S. trials over whether the popular herbicide causes cancer.
- Ancestry Steps Up 23andMe Rivalry With DNA Health TestsConsumer genomics firm Ancestry will begin selling DNA health test kits, setting up a showdown with 23andMe.
- E-Cigarette Sales Slow Dramatically in Wake of Health Warnings“The impacts of vapor related illnesses have led to substantial sequential declines,” wrote Cowen analyst Vivien Azer.
- Could Lowering Drug Prices Hamper Drug Innovation?—Brainstorm HealthHappy Monday, readers. The Congressional Budget Office (CBO)—that scorekeeper of how federal policies will affect business, the government, and the public at large—has a preliminary report out on how House Speaker Nancy Pelosi’s proposed drug pricing legislation may affect the federal budget, public health programs, and the drug industry at large. It’s a lot to […]
Skip to Content